Pathfinder Cell Therapy, Inc. (PFND)

Pathfinder Cell Therapy Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010
Period Ending	Sep 30, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010
Net Income	-1.08	-1.39	-1.71	-2.16	-11.27	-1.29
Depreciation & Amortization	0	0	0.01	0.02	0.02	0.01
Asset Writedown & Restructuring Costs	-	-	0.16	-	8.13	-
Stock-Based Compensation	-	0	0.01	0.01	0.53	-
Other Operating Activities	-	-	-0.25	0.02	0.1	0.46
Change in Accounts Receivable	-	-	0.03	0.03	0.05	-
Change in Inventory	-	-	0.03	0.02	0.03	-
Change in Accounts Payable	0.14	0.04	0.11	-0.17	0	-0
Change in Other Net Operating Assets	0.36	0.39	-0	0.21	0.09	-0.01
Operating Cash Flow	-0.58	-0.96	-1.6	-2.02	-2.33	-0.83
Cash Acquisitions	-	-	-	-	0.01	-
Other Investing Activities	-	-	-	-	-0.85	-0.32
Investing Cash Flow	-	-	-	-	-0.84	-0.32
Short-Term Debt Issued	-	1.01	1.74	1.97	2.13	0.85
Total Debt Issued	0.61	1.01	1.74	1.97	2.13	0.85
Short-Term Debt Repaid	-	-0.06	-0.1	-0.13	-0.06	-
Total Debt Repaid	-0.05	-0.06	-0.1	-0.13	-0.06	-
Net Debt Issued (Repaid)	0.56	0.95	1.64	1.84	2.06	0.85
Issuance of Common Stock	-	-	-	-	1.28	0.31
Financing Cash Flow	0.56	0.95	1.64	1.84	3.35	1.16
Net Cash Flow	-0.02	-0.02	0.04	-0.19	0.18	0
Levered Free Cash Flow	-0.22	-0.49	-1.05	-1.32	-1.01	-0.51
Unlevered Free Cash Flow	-0.03	-0.32	-0.92	-1.26	-0.94	-0.51
Change in Working Capital	0.5	0.43	0.17	0.08	0.16	-0.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.